Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL28541014 | 1.00 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| Cyclopropane SCHEMBL27675914 | 1.00 | — | — | |
| Cyclooctane SCHEMBL28059520 | 1.00 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| Isothiocyanate SCHEMBL17274364 | 1.00 | — | — | |
| Cyclopentane SCHEMBL3823201 | 1.00 | — | — | |
| Cyclohexane SCHEMBL2219906 | 1.00 | — | — | |
| Isothiocyanate SCHEMBL133963 | 0.82 | — | — | |
| Isothiocyanate SCHEMBL8940171 | 0.82 | ALDH1A1 (0.43) | ALDH1A1LMNA | |
| Isothiocyanate SCHEMBL331482 | 0.82 | — | — | |
| Isothiocyanate SCHEMBL4002 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10696778-B1 | Methods of making polymers using isosorbide | NOVOL, INC. (US) | 2020-06-30 | — | — | US | claimed |
| US-20260146189-A1 | ADHESIVE COMPOSITION, THE PREPARATION METHOD AND USE THEREOF | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-28 | — | — | US | disclosed |
| EP-4748866-A1 | AQUEOUS POLYURETHANE DISPERSIONS AND APPLICATIONS THEREOF | Covestro Deutschland AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260140398-A1 | OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2026-05-21 | — | — | US | disclosed |
| US-12630694-B2 | Polythiol composition, polymerizable composition, resin, molded body, optical material, and lens | MITSUI CHEMICALS, INC. (JP) | 2026-05-19 | — | — | US | disclosed |
| EP-3861977-B1 | (METH)ACRYLATE, MONOMER COMPOSITION, MOLDED BODY, COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-05-06 | — | — | EP | disclosed |
| EP-4733341-A1 | POLYMERIZABLE COMPOSITION AND METHOD FOR PRODUCING SAME, RESIN, MOLDED BODY, OPTICAL MATERIAL, AND LENS | Mitsui Chemicals, Inc. (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-12605306-B2 | Method of manufacturing monomer composition, raw material composition, monomer composition, curable composition, and molded body | MITSUI CHEMICALS, INC. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12583964-B2 | Polythiol composition, polymerizable composition, resin, molded article, optical material, and lens | MITSUI CHEMICALS, INC. (JP) | 2026-03-24 | — | — | US | disclosed |
| EP-3983466-B1 | AQUEOUS POLYURETHANE DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-5283312-A | Colorless, transparent, high refractive index, heat resistance, low dispersion; polythiourethanes | MITSUI TOATSU CHEMICALS, INC. (JP) | 1994-02-01 | — | — | US | disclosed |
| EP-0553801-A1 | Use of sulfur-containing acid phosphoric ester as internal release agent | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-08-04 | — | — | EP | disclosed |
| EP-0551867-A1 | Laminated transparent plastic material and polymerizable monomer | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-07-21 | — | — | EP | disclosed |
| EP-0378895-B1 | A MERCAPTO COMPOUND, A HIGH REFRACTIVE INDEX RESIN AND LENS AND A PROCESS FOR PREPARING THEM | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-07-14 | — | — | EP | disclosed |
| EP-0549808-A1 | TRANSPARENT PLASTIC MATERIAL | SEIKO EPSON CORPORATION (JP) | 1993-07-07 | — | — | EP | disclosed |
| US-5191055-A | Polythiourethanes | MITSUI TOATSU CHEMICALS, INC. (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0528590-A1 | Mercapto compound, its preparation process, and sulfur-containing urethane resins and lenses using the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-02-24 | — | — | EP | disclosed |
| US-5087758-A | Polythiourethane monomer | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-02-11 | — | — | US | disclosed |
| US-5084545-A | Polythiourethanes for impact strength, lightweight lenses | MITSUI TOATSU CHEMICALS, INC. (JP) | 1992-01-28 | — | — | US | disclosed |
| US-3993632-A | PROPELLANT BINDER | SHELL OIL COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630694-B2 | Polythiol composition, polymerizable composition, resin, molded body, optical material, and lens | TXNL1, ALG3, TCOF1 | ALDH1A1 2820/4885LMNA 1176/4885 |
| US-20260140398-A1 | OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | CRYAA, FEM1B, MAPRE1 | ALDH1A1 588/4885LMNA 685/4885 |
| US-12605306-B2 | Method of manufacturing monomer composition, raw material composition, monomer composition, curable composition, and molded body | ADH1A, ADH1C, ADH5 | ALDH1A1 15/4885LMNA 4328/4885 |
| US-10696778-B1 | Methods of making polymers using isosorbide | PUF60, MACF1, PPIE | ALDH1A1 178/4885LMNA 2736/4885 |
| US-20260146189-A1 | ADHESIVE COMPOSITION, THE PREPARATION METHOD AND USE THEREOF | PUF60, XRCC6, F7 | ALDH1A1 780/4885LMNA 532/4885 |
| US-12583964-B2 | Polythiol composition, polymerizable composition, resin, molded article, optical material, and lens | EPN1, SEM1, PFN1 | ALDH1A1 2000/4885LMNA 1672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.